RECENT NEWS

UpFront Diagnostics has announced CE mark approval for LVOne - the world's first rapid blood test to diagnose stroke, and the first device of its kind to achieve this certification.

Leica Biosystems has launched its new HistoCore LIGHTNING C Laser Cassette Printer, designed to help laboratories standardise critical histopathology workflows, improve traceability and move from sample to answer with greater speed and certainty.

A new approach combining information about proteins in the blood with genomic data could help diagnose some people with rare conditions who remained undiagnosed after genome sequencing, according to new research.

Two leading UK research institutes, The Rosalind Franklin Institute and Henry Royce Institute will share just over £160 million of public funding from the UK government through UK Research and Innovation (UKRI) for the next five years, to develop new health tech and deepen understanding of advanced materials.

Scientists from the University of Galway have uncovered a surprising link between commonly used anti-cancer drugs and antibiotics that could offer a potential new approach to tackling infections caused by antibiotic-resistant microorganisms.

Young adults, particularly university students, remain at increased risk from meningococcal meningitis and septicaemia, with new figures showing that meningitis B (MenB) was responsible for 97% of invasive meningococcal disease cases in 15 to 24-year-olds (93 of 96 cases) in England during 2025 to 2026.

Researchers have demonstrated that a streamlined genetic testing approach could identify more people with inherited breast cancer risk, while reducing the burden on NHS breast and genetic services.

International private health firm PureHealth has announced the expansion of its platform into laboratory operations across the UK, with its Circle Health Group subsidiary taking over Unilabs' existing UK operations.

Proscia has announced that Unilabs, one of the leading providers of medical diagnostic services in Europe, is leveraging the Concentriq platform to support the advancement of digital pathology across its network.

London-based pathology provider Synnovis is to expand its use of drones in the capital to transport urgent samples from both Guy’s Hospital and St Thomas’ Hospital to its Blackfriars laboratory hub.

Sysmex Europe and Cytek Biosciences have announced a strategic collaboration across Europe to enhance clinical flow cytometry workflows and expand access to innovative diagnostic solutions.

The National Commission into the Regulation of AI in Healthcare has published its recommendations on how the UK can strengthen the regulation of AI in healthcare, so it remains safe, keeps pace with innovation, and continues to earn people’s trust.

Molecular diagnostics firm Yourgene Health has announced the commercial launch of its IVDR-certified Yourgene Insight DPYD assay, expanding the company's clinical genetics portfolio across regulated European markets.

Eppendorf has announced the launch of the Centrifuge 5811 R, a refrigerated, multipurpose benchtop centrifuge designed to support a wide range of laboratory workflows

The UK Health Security Agency (UKHSA) has highlighted that almost half of eligible primary-school aged children did not receive a influenza vaccine last year, as roll out of vaccines in schools starts ahead of this winter.

Genomic research and diagnostic firm OGT has announced the expansion of its SureSeq Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 384 uniquely indexed samples in a single sequencing run.

Researchers developed a novel ‘mosaic’ nanoparticle vaccine platform that delivers broad-spectrum mucosal protection against emerging coronaviruses.

A new study has found that sleep app cough data can detect respiratory illness and signal outbreaks early.

Hamamatsu is to collaborate with AIxMed, a developer of software for digital cytology workflows, to evaluate the integration of AIxMed's ScanPilot with selected Hamamatsu NanoZoomer whole-slide scanner configurations for research and development workflows.

The World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for Cepheid’s Xpert Hemorrhagic Fever Panel test to support the diagnostic response to the Ebola Bundibugyo (BDBV) outbreak in the Democratic Republic of the Congo (DRC).